Senate Hearing: Addressing Substance Misuse and Treatment Fraud
January 1, 2021
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
This hearing evaluates the effectiveness of federal laws and oversight in managing the national opioid crisis, which impacts the allocation of federal health resources and the availability of addiction treatment services for approximately 20 million Americans.
Potentially affected actors named in the source documents. Mention is not a position.
Individuals with substance use disorders
Federal policy changes and oversight of treatment facilities directly impact the availability and quality of their care.
Department of Health and Human Services
The agency is responsible for implementing the SUPPORT Act and managing federal health initiatives.
Last recorded activity January 1, 2021.
Next step not available in the current record.
Summary
Key Facts
- The hearing marked the one-year anniversary of the SUPPORT Act.
- Approximately 130 Americans die from an opioid overdose every day.
- Roughly 20 million Americans struggle with substance use disorder.
- The committee reviewed federal implementation of the SUPPORT Act and identified ongoing challenges in treatment access.
- The hearing addressed the prevalence of scams and fraud within the substance abuse treatment sector.
- The committee received testimony from the Surgeon General, the GAO, the HHS Office of Inspector General, and the organization Shatterproof.
Frequently Asked Questions
What is the SUPPORT Act?
Why was this hearing held?
Why It Matters
This hearing evaluates the effectiveness of federal laws and oversight in managing the national opioid crisis, which impacts the allocation of federal health resources and the availability of addiction treatment services for approximately 20 million Americans.
News Coverage
Sponsors
Show 1 more sponsor
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Focus on Treatment Fraud
The hearing highlights a shift in focus from purely medical response to addressing systemic fraud and scams within the addiction treatment industry.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance80How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment20Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools